NASDAQ:SMTI Sanara MedTech (SMTI) Stock Forecast, Price & News $39.93 +0.06 (+0.15%) (As of 01:05 PM ET) Add Compare Share Share Today's Range$39.93▼$40.7750-Day Range$33.54▼$49.6852-Week Range$18.89▼$50.18Volume3,964 shsAverage Volume15,265 shsMarket Capitalization$334.73 millionP/E RatioN/ADividend YieldN/APrice Target$50.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Sanara MedTech (NASDAQ:SMTI) StockSanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.Read More Receive SMTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter. Email Address SMTI Stock News HeadlinesMay 30, 2023 | americanbankingnews.comSanara MedTech Inc. (NASDAQ:SMTI) Sees Significant Decrease in Short InterestMay 24, 2023 | msn.comDown -14.23% in 4 Weeks, Here's Why Sanara MedTech Inc. (SMTI) Looks Ripe for a TurnaroundJune 9, 2023 | Edge On The Street (Ad)Graphite versus Lithium - What Investors Should KnowOver 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.May 24, 2023 | americanbankingnews.comCantor Fitzgerald Comments on Sanara MedTech Inc.'s FY2023 Earnings (NASDAQ:SMTI)May 15, 2023 | msn.comSanara MedTech: Q1 Earnings InsightsMay 15, 2023 | finance.yahoo.comSanara MedTech Inc. Announces First Quarter 2023 ResultsMay 8, 2023 | americanbankingnews.comSanara MedTech (SMTI) Scheduled to Post Quarterly Earnings on MondayMay 5, 2023 | finance.yahoo.comSanara MedTech Inc.'s (NASDAQ:SMTI) Price In Tune With RevenuesJune 9, 2023 | Edge On The Street (Ad)Graphite versus Lithium - What Investors Should KnowOver 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.May 3, 2023 | finance.yahoo.comSanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call DatesApril 24, 2023 | americanbankingnews.comContrasting Sanara MedTech (NASDAQ:SMTI) & Advanced Biomedical Technologies (OTCMKTS:ABMT)April 4, 2023 | finance.yahoo.comSanara MedTech Inc. Announces 510(k) Clearance for BIASURGE™ Advanced Surgical SolutionMarch 24, 2023 | insidermonkey.comSanara MedTech Inc. (NASDAQ:SMTI) Q4 2022 Earnings Call TranscriptMarch 24, 2023 | finance.yahoo.comWe Think Sanara MedTech (NASDAQ:SMTI) Can Afford To Drive Business GrowthMarch 24, 2023 | americanbankingnews.comFY2023 EPS Estimates for Sanara MedTech Inc. (NASDAQ:SMTI) Reduced by AnalystMarch 21, 2023 | americanbankingnews.comSanara MedTech (NASDAQ:SMTI) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPSMarch 21, 2023 | americanbankingnews.comSanara MedTech (NASDAQ:SMTI) Announces Earnings Results, Misses Estimates By $0.04 EPSMarch 20, 2023 | finance.yahoo.comSanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 ResultsMarch 17, 2023 | benzinga.comEarnings Outlook For Sanara MedTechMarch 6, 2023 | finance.yahoo.comSanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Earnings Release and Conference Call DatesFebruary 22, 2023 | msn.comSanara MedTech expects 119% growth in Q4 toplineFebruary 22, 2023 | finance.yahoo.comSanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2022February 14, 2023 | finance.yahoo.comSanara MedTech Inc. (NASDAQ:SMTI) On The Verge Of Breaking EvenJanuary 18, 2023 | finance.yahoo.comSanara MedTech Inc.'s (NASDAQ:SMTI) largest shareholders are individual investors with 34% ownership, insiders own 32%January 10, 2023 | thetimes.co.ukFit for the future: how medtech is set to transform our livesDecember 8, 2022 | seekingalpha.comSanara MedTech: Triple-Digit Revenue Upside In Q3, Expanding Footprint, Reaffirm BuyNovember 21, 2022 | finance.yahoo.comSanara MedTech to Participate in Two Upcoming Healthcare ConferencesSee More Headlines SMTI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SMTI Company Calendar Last Earnings3/20/2023Today6/09/2023Next Earnings (Estimated)8/21/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SMTI CUSIPN/A CIK714256 Webwww.wndm.com Phone(817) 529-2300FaxN/AEmployees40Year FoundedN/APrice Target and Rating Average Stock Price Forecast$50.00 High Stock Price Forecast$50.00 Low Stock Price Forecast$50.00 Forecasted Upside/Downside+23.4%Consensus RatingN/A Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($1.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,940,000.00 Net Margins-18.67% Pretax Margin-22.40% Return on Equity-25.60% Return on Assets-18.26% Debt Debt-to-Equity RatioN/A Current Ratio1.79 Quick Ratio1.47 Sales & Book Value Annual Sales$53.55 million Price / Sales6.34 Cash FlowN/A Price / Cash FlowN/A Book Value$5.02 per share Price / Book8.07Miscellaneous Outstanding Shares8,383,000Free Float3,756,000Market Cap$339.68 million OptionableNot Optionable Beta1.82 Key ExecutivesZach FlemingChief Executive OfficerCallon NicholsVice President-Corporate OperationsMichael D. McNeilChief Financial Officer & SecretaryRebecca E. McMahonPresident-Research & DevelopmentProdromos VervereliVice President-Medical AffairsKey CompetitorsVicarious SurgicalNYSE:RBOTInogenNASDAQ:INGNEargoNASDAQ:EARCollPlant BiotechnologiesNASDAQ:CLGNAvanos MedicalNYSE:AVNSView All CompetitorsInsiders & InstitutionsPrelude Capital Management LLCSold 2,324 shares on 6/1/2023Ownership: 0.078%Ameriprise Financial Inc.Bought 3,886 shares on 5/22/2023Ownership: 0.212%JPMorgan Chase & Co.Bought 3,173 shares on 5/18/2023Ownership: 0.038%Geode Capital Management LLCBought 1,252 shares on 5/16/2023Ownership: 0.350%State Street CorpBought 600 shares on 5/16/2023Ownership: 0.124%View All Insider TransactionsView All Institutional Transactions SMTI Stock - Frequently Asked Questions What is Sanara MedTech's stock price forecast for 2023? 0 Wall Street research analysts have issued 1 year price objectives for Sanara MedTech's shares. Their SMTI share price forecasts range from $50.00 to $50.00. On average, they anticipate the company's stock price to reach $50.00 in the next twelve months. This suggests a possible upside of 23.4% from the stock's current price. View analysts price targets for SMTI or view top-rated stocks among Wall Street analysts. How have SMTI shares performed in 2023? Sanara MedTech's stock was trading at $45.50 on January 1st, 2023. Since then, SMTI shares have decreased by 10.9% and is now trading at $40.52. View the best growth stocks for 2023 here. Are investors shorting Sanara MedTech? Sanara MedTech saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 62,900 shares, a drop of 14.0% from the April 30th total of 73,100 shares. Based on an average daily trading volume, of 18,200 shares, the short-interest ratio is presently 3.5 days. Currently, 1.9% of the company's stock are sold short. View Sanara MedTech's Short Interest. When is Sanara MedTech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023. View our SMTI earnings forecast. How were Sanara MedTech's earnings last quarter? Sanara MedTech Inc. (NASDAQ:SMTI) posted its earnings results on Monday, March, 20th. The company reported ($0.51) EPS for the quarter. The company earned $15.32 million during the quarter. Sanara MedTech had a negative net margin of 18.67% and a negative trailing twelve-month return on equity of 25.60%. What other stocks do shareholders of Sanara MedTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sanara MedTech investors own include Lakeland Industries (LAKE), Ovintiv (OVV), SIG (SHI), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), American Airlines Group (AAL), Abbott Laboratories (ABT), Aurora Cannabis (ACB), AC Immune (ACIU) and Applied Genetic Technologies (AGTC). What is Sanara MedTech's stock symbol? Sanara MedTech trades on the NASDAQ under the ticker symbol "SMTI." Who are Sanara MedTech's major shareholders? Sanara MedTech's stock is owned by a variety of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.35%), Susquehanna International Group LLP (0.30%), Ameriprise Financial Inc. (0.21%), Jane Street Group LLC (0.21%), HRT Financial LP (0.13%) and State Street Corp (0.12%). Insiders that own company stock include Shawn M Bowman and Zachary B Fleming. View institutional ownership trends. How do I buy shares of Sanara MedTech? Shares of SMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sanara MedTech's stock price today? One share of SMTI stock can currently be purchased for approximately $40.52. How much money does Sanara MedTech make? Sanara MedTech (NASDAQ:SMTI) has a market capitalization of $339.68 million and generates $53.55 million in revenue each year. The company earns $-7,940,000.00 in net income (profit) each year or ($1.25) on an earnings per share basis. How can I contact Sanara MedTech? Sanara MedTech's mailing address is 1200 Summit Avenue Suite 414, Fort Worth TX, 76102. The official website for the company is www.wndm.com. The company can be reached via phone at (817) 529-2300 or via email at ir@sanaramedtech.com. This page (NASDAQ:SMTI) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.